Contrary to the U.S. and Europe, Chinese Chloroquine Phosphate API Prices Demonstrate an Upward Trend
Contrary to the U.S. and Europe, Chinese Chloroquine Phosphate API Prices Demonstrate an Upward Trend

Contrary to the U.S. and Europe, Chinese Chloroquine Phosphate API Prices Demonstrate an Upward Trend

  • 09-Dec-2022 5:30 PM
  • Journalist: Harold Finch

Across the globe, Chloroquine Phosphate API prices showcased mixed trends in November 2022 due to fluctuating market fundamentals. The fear of a recession and economic downturn reduced demand in European and North American regions. In contrast, a shortage of inventories among Chinese domestic manufacturers due to slow manufacturing activity amid lockdown restrictions caused an increasing price trend in China.

Chloroquine Phosphate API prices followed a downward price trajectory in Germany, with values decreasing by 2.4% in November 2022 as domestic demand from the end-user Pharmaceutical industry was lower than expected, backed by pessimistic market sentiments. However, German supply chain disruption due to declines in order started to subside, which comforted related end-users sectors. Moreover, the more even distribution of products might further erode the market's fundamentals rather than bring about equilibrium. However, market insiders held a bearish mentality, and downstream users were cautious. Also, ample stock levels provoked traders to actively reduce Chloroquine Phosphate API prices to destock their endless inventory due to the upcoming Christmas Holiday.

Similarly, Chloroquine Phosphate API prices in November 2022 fell more than 2.5% in the U.S. domestic market due to declining demand from the end-user sector. The situation put pressure on the suppliers to clear out their stocks at a discounted price. In addition, the freight costs from Asia to the U.S. were also about to decrease as port congestion concerns subsided somewhat. As a result, the Chloroquine Phosphate API market was under pressure, due to which participants noted a dip in underlying profits.

On the other hand, in China, Chloroquine Phosphate API prices increased by more than 2% monthly due to enhanced interest from the international downstream Pharmaceutical and Healthcare industries. Despite dormant demand in the Chinese domestic market due to lockdowns implemented to limit the spread of COVID-19, the local market participants recognized positive responses from overseas buyers. However, the suppliers raised Chloroquine Phosphate API prices for international markets to sustain their profit margin as they had limited stock to meet the surging demand.

According to ChemAnalyst's research, it is anticipated that the global Chloroquine Phosphate API prices may experience a decline in December 2022 due to sluggish market sentiments. However, the weak end-user demand exacerbated by the slowdown in trade activity ahead of the Christmas Holiday might result in a price drop.

Related News

German Clindamycin Phosphate Values Decline Due to Crippling Downstream Demand
  • 15-Sep-2022 6:53 PM
  • Journalist: Nicholas Seifield


clock image

Track Real Time Prices